Sterling Investment Advisors (Pennsylvania)’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,200
Closed -$8K 343
2022
Q2
$8K Hold
2,200
﹤0.01% 421
2022
Q1
$10K Hold
2,200
﹤0.01% 432
2021
Q4
$13K Hold
2,200
﹤0.01% 416
2021
Q3
$13K Hold
2,200
﹤0.01% 413
2021
Q2
$28K Hold
2,200
0.01% 318
2021
Q1
$23K Hold
2,200
0.01% 319
2020
Q4
$20K Hold
2,200
0.01% 308
2020
Q3
$14K Hold
2,200
0.01% 325
2020
Q2
$11K Hold
2,200
﹤0.01% 339
2020
Q1
$7K Hold
2,200
﹤0.01% 332
2019
Q4
$16K Hold
2,200
0.01% 313
2019
Q3
$11K Hold
2,200
0.01% 338
2019
Q2
$9K Hold
2,200
﹤0.01% 354
2019
Q1
$8K Hold
2,200
﹤0.01% 355
2018
Q4
$3K Hold
2,200
﹤0.01% 372
2018
Q3
$14K Hold
2,200
0.01% 332
2018
Q2
$14K Hold
2,200
0.01% 315
2018
Q1
$15K Hold
2,200
0.01% 298
2017
Q4
$28K Hold
2,200
0.02% 237
2017
Q3
$26K Sell
2,200
-1,500
-41% -$22.2K 0.02% 236
2017
Q2
$55K Hold
3,700
0.04% 174
2017
Q1
$35K Hold
3,700
0.03% 196
2016
Q4
$33K Buy
+3,700
New +$33.2K 0.03% 178

Other funds holding MDXG

Sterling Investment Advisors (Pennsylvania)'s MDXG Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of MiMedx Group (MDXG) in Q3 2022, closing a stake of 2,200 shares — an estimated $8K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in MDXG in Q4 2016 and held it in 23 quarters. The position peaked at $55K in Q2 2017. 144 funds tracked by Wall St. Rank hold MDXG as of Q3 2022.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining MiMedx Group position as of Q3 2022 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 2,200 MiMedx Group shares in Q3 2022, an estimated $8K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in MiMedx Group in Q4 2016 and held it in 23 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s MiMedx Group position peaked at $55K in Q2 2017.
  • 144 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.